3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Solid Tumours
5
Melanoma
5
Neurofibromatosis 1
4
Lung Neoplasms
4
Rectal Neoplasms
3
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Breast Neoplasms
3
Biliary Tract Neoplasms
3
Neurofibroma, Plexiform
2
Uveal Melanoma
1
Solid Tumors
1
Renal Insufficiency
1
Primary Myelofibrosis
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Cancer
1
Locally Advanced or Metastatic Solid Tumors
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Healthy Volunteers Pharmacokinetic Study
1
Gallbladder Neoplasms
1
Disease Progression
1
Cholangiocarcinoma
1
Advanced Non Small Cell Lung Cancer
1
Advanced Cancer
1
Adult Solid Neoplasm
1
Interventions
Gemcitabine
11
Cisplatin
9
Oxaliplatin
7
Leucovorin
6
Irinotecan
6
Fluorouracil
5
Taxes
3
Radiotherapy
3
Platinum
3
Interleukin-12 Subunit p35
3
Erlotinib Hydrochloride
3
Capecitabine
3
Albumin-Bound Paclitaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
tipifarnib
1
sargramostim
1
pembrolizumab
1
motexafin gadolinium
1
merestinib
1
guadecitabine
1
fludarabine
1
entinostat
1
durvalumab
1
dehydroftorafur
1
aldesleukin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Gallbladder Neoplasms
×
AZD 6244
×
Clear all
NCT01242605
2016-05-13
ABC-04
University College, London
Phase 1
Completed
13 enrolled